CA3301254A1 - Formulations d'ériodictyol - Google Patents

Formulations d'ériodictyol

Info

Publication number
CA3301254A1
CA3301254A1 CA3301254A CA3301254A CA3301254A1 CA 3301254 A1 CA3301254 A1 CA 3301254A1 CA 3301254 A CA3301254 A CA 3301254A CA 3301254 A CA3301254 A CA 3301254A CA 3301254 A1 CA3301254 A1 CA 3301254A1
Authority
CA
Canada
Prior art keywords
eriodictyol
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3301254A
Other languages
English (en)
Inventor
Taylor OSWALD
Original Assignee
Debut Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debut Biotechnology Inc filed Critical Debut Biotechnology Inc
Publication of CA3301254A1 publication Critical patent/CA3301254A1/fr
Pending legal-status Critical Current

Links

CA3301254A 2023-08-09 2024-08-09 Formulations d'ériodictyol Pending CA3301254A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/531,606 2023-08-09
US63/531,603 2023-08-09

Publications (1)

Publication Number Publication Date
CA3301254A1 true CA3301254A1 (fr) 2025-02-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP4271402A4 (fr) Composition de bl-8040
EP4251153A4 (fr) Formulations lyophilisées de tegavivint
CA3301254A1 (fr) Formulations d'ériodictyol
EP4099999A4 (fr) Formulations de docétaxel
CA3291219A1 (fr) Formulations de pectolinarigénine
CA3301645A1 (fr) Formulations de dihydrokaempférol
IL326447A (en) Eriodictyol formulations
HK40117787A (en) Stable formulations of shr0302
HK40112689A (en) Formulations of radiprodil
EP4157262A4 (fr) Formulations pharmaceutiques de pilocarpine r-(+)-lipoate
CA3291772A1 (fr) Formulations de naringénine
HK40106938A (en) Formulations of l-asparaginase
HK40102138A (en) Formulations of psilocybin
IL326508A (en) Dihydrokaempferol formulations
HK40122546A (en) Combination formulation of cedazuridine
AU2024307383A1 (en) Novel formulations
CA3294652A1 (fr) Nouvelles formulations
AU2025904106A0 (en) Improved formulations
AU2024903027A0 (en) Improved formulations
HK40129881A (zh) 贝祖拉替尼制剂
AU2022903170A0 (en) Stable API Formulations
HK40101567A (en) Oral formulations of tenapanor
AU2024900796A0 (en) Formulations
CA3296099A1 (fr) Formulation solide de pudafensine à administrer par voie orale
CA3277614A1 (fr) Formulations de bezuclastinib